This case series from an LMIC describes three patients with type 2 diabetes mellitus and multiple comorbidities, including hypertension, ischemic stroke, chronic kidney disease, and poliomyelitis developed EuDKA associated with SGLT2 inhibitor (SGLT2i) use. This evidence concerns the gene SLC5A2 and ischemic stroke.